Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Long-Term Investments (2021)

Historic Long-Term Investments for Aligos Therapeutics (ALGS) over the last 1 years, with Q4 2021 value amounting to $15.1 million.

  • Aligos Therapeutics' Long-Term Investments changed N/A to $15.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $15.1 million, marking a year-over-year change of. This contributed to the annual value of $15.1 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, Aligos Therapeutics' Long-Term Investments is $15.1 million.
  • Aligos Therapeutics' 5-year Long-Term Investments high stood at $15.1 million for Q4 2021, and its period low was $492000.0 during Q3 2021.